CA2838971C - Production method of imidazole derivatives - Google Patents

Production method of imidazole derivatives Download PDF

Info

Publication number
CA2838971C
CA2838971C CA2838971A CA2838971A CA2838971C CA 2838971 C CA2838971 C CA 2838971C CA 2838971 A CA2838971 A CA 2838971A CA 2838971 A CA2838971 A CA 2838971A CA 2838971 C CA2838971 C CA 2838971C
Authority
CA
Canada
Prior art keywords
mixture
compound
added
stirred
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2838971A
Other languages
English (en)
French (fr)
Other versions
CA2838971A1 (en
Inventor
Yoichi Kawabata
Yasuhiro Sawai
Kazuaki Kanno
Naotaka Sawada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46458578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2838971(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Publication of CA2838971A1 publication Critical patent/CA2838971A1/en
Application granted granted Critical
Publication of CA2838971C publication Critical patent/CA2838971C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA2838971A 2011-06-15 2012-06-14 Production method of imidazole derivatives Expired - Fee Related CA2838971C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011133712 2011-06-15
JP2011-133712 2011-06-15
PCT/JP2012/065795 WO2012173280A1 (en) 2011-06-15 2012-06-14 Production method of imidazole derivatives

Publications (2)

Publication Number Publication Date
CA2838971A1 CA2838971A1 (en) 2012-12-20
CA2838971C true CA2838971C (en) 2019-07-30

Family

ID=46458578

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2838971A Expired - Fee Related CA2838971C (en) 2011-06-15 2012-06-14 Production method of imidazole derivatives

Country Status (27)

Country Link
US (2) US9278938B2 (enExample)
EP (1) EP2721010B1 (enExample)
JP (1) JP6082353B2 (enExample)
KR (1) KR20140028069A (enExample)
CN (1) CN103608334B (enExample)
AR (1) AR086926A1 (enExample)
AU (1) AU2012270496A1 (enExample)
BR (1) BR112013030888A2 (enExample)
CA (1) CA2838971C (enExample)
CL (1) CL2013003492A1 (enExample)
CO (1) CO6852075A2 (enExample)
CR (1) CR20130655A (enExample)
DO (1) DOP2013000287A (enExample)
EA (1) EA201490019A1 (enExample)
EC (1) ECSP14013128A (enExample)
ES (1) ES2554454T3 (enExample)
IL (1) IL229566A0 (enExample)
MA (1) MA35809B1 (enExample)
MX (1) MX2013014009A (enExample)
PE (1) PE20141326A1 (enExample)
PH (1) PH12013502567A1 (enExample)
SG (1) SG195036A1 (enExample)
TN (1) TN2013000481A1 (enExample)
TW (1) TW201307295A (enExample)
UY (1) UY34130A (enExample)
WO (1) WO2012173280A1 (enExample)
ZA (1) ZA201308884B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016054129A1 (en) * 2014-09-30 2016-04-07 Stc.Unm Graphene-based inorganic-organic hybrid materials and separation of racemic mixtures
US20200033307A1 (en) * 2018-07-25 2020-01-30 Honeywell International Inc. Method of determining an amount of water in a sample using a derivative of imidazole and a hydrogen halide donor
KR102253950B1 (ko) * 2019-07-24 2021-05-20 (주)에니켐텍 신규한 메데토미딘 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5832880A (ja) * 1981-08-24 1983-02-25 Isukura Sangyo Kk ハリントニンの部分合成方法
US6713632B1 (en) 1999-06-22 2004-03-30 Takeda Chemical Industries, Ltd. Process for the preparation of imidazole derivatives
PE20010781A1 (es) 1999-10-22 2001-08-08 Takeda Chemical Industries Ltd Compuestos 1-(1h-imidazol-4-il)-1-(naftil-2-sustituido)etanol, su produccion y utilizacion
DE10031604A1 (de) 2000-06-29 2002-01-17 Consortium Elektrochem Ind Verfahren zur Herstellung von beta-Hydroxy- und beta-Aminocarbonylverbindungen
TWI306099B (en) 2000-11-17 2009-02-11 Takeda Chemical Industries Ltd Novel imidazole derivatives, production method thereof and use thereof
CN1289434C (zh) 2002-01-04 2006-12-13 皇家飞利浦电子股份有限公司 烧结体和电灯
US7662974B2 (en) * 2002-01-10 2010-02-16 Takeda Pharmaceutical Company Limited Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
EP1394140A1 (de) * 2002-08-14 2004-03-03 Consortium für elektrochemische Industrie GmbH Enantioselektives Reformatsky-Verfahren zur Herstellung von optisch aktiven Alkoholen, Aminen und deren Derivaten
EP2164409B1 (en) 2007-06-29 2018-08-08 Atheromed, Inc. Atherectomy system

Also Published As

Publication number Publication date
ECSP14013128A (es) 2014-02-28
ZA201308884B (en) 2015-02-25
EA201490019A1 (ru) 2014-04-30
CN103608334A (zh) 2014-02-26
AU2012270496A1 (en) 2013-12-19
JP6082353B2 (ja) 2017-02-15
CN103608334B (zh) 2015-12-23
US20140100373A1 (en) 2014-04-10
US10005780B2 (en) 2018-06-26
SG195036A1 (en) 2013-12-30
TW201307295A (zh) 2013-02-16
PH12013502567A1 (en) 2014-01-27
CO6852075A2 (es) 2014-01-30
CL2013003492A1 (es) 2014-07-18
DOP2013000287A (es) 2014-02-16
MX2013014009A (es) 2014-03-12
AR086926A1 (es) 2014-01-29
EP2721010B1 (en) 2015-09-09
TN2013000481A1 (en) 2015-03-30
CR20130655A (es) 2014-03-03
ES2554454T3 (es) 2015-12-21
CA2838971A1 (en) 2012-12-20
UY34130A (es) 2013-01-31
EP2721010A1 (en) 2014-04-23
PE20141326A1 (es) 2014-10-16
JP2014520066A (ja) 2014-08-21
BR112013030888A2 (pt) 2017-03-21
MA35809B1 (fr) 2014-12-01
US9278938B2 (en) 2016-03-08
WO2012173280A1 (en) 2012-12-20
US20160244454A1 (en) 2016-08-25
KR20140028069A (ko) 2014-03-07
IL229566A0 (en) 2014-01-30

Similar Documents

Publication Publication Date Title
EP2190804B1 (en) Process and intermediates for preparing integrase inhibitors
IL197527A (en) History - 4-Oxoquoquinoline and Process and Intermediate Compounds for Preparation of Integration Inhibitors
CA2838971C (en) Production method of imidazole derivatives
US5426196A (en) Synthesis of diaryl methanes
KR101726116B1 (ko) 치환된 피롤리딘-2-카복스아미드의 비대칭 합성
US20050245750A1 (en) Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative
CN110831944A (zh) 通过极有效制备中间体2,4,5-三氟苯乙酸来制备西他列汀的有效方法
JP5925899B2 (ja) ビアリール化合物の製造方法
TW202035407A (zh) 3-溴-5-(2-乙基咪唑並[1,2-a]吡啶-3-羰基)-2-羥基苯甲腈的合成
CN108218762B (zh) 一种2位季碳吲哚-3-酮类化合物的合成方法
CN103517897A (zh) 环戊二烯并喹唑啉的合成
CN103224498B (zh) 两种唑并喹唑啉酮稠杂环的新合成方法
CN105130982B (zh) 一种咪唑并杂环氨基二硫代甲酸酯及其制备方法
CN103333144B (zh) 一种2-硫基-3-卤代苯并呋喃化合物及其合成方法和用途
CN114213278B (zh) 一种苄重氮基苯乙酮类化合物的合成方法及苄重氮基苯乙酮类化合物
AU772966B2 (en) Method for preparing substituted (1,4)diazepino(6,7,1-hi)indol-4-ones
Li et al. SYNTHESIS OF LESINURAD VIA A MULTICOMPONENT REACTION WITH ISOCYANIDES AND DISULFIDES
JP2004519444A (ja) 2−(2−エトキシフェニル)置換されたイミダゾトリアジノンの製造方法
JP2024525966A (ja) B型肝炎ウイルスヌクレオカプシド阻害剤の製造方法
JPH0214348B2 (enExample)
HK40056618B (en) Synthesis of 3-bromo-5-(2-ethylimidazo[1,2-alpha]pyridine-3-carbonyl)-2-hydroxybenzonitrile
JP2006515848A (ja) シリルエーテル
JPH09176129A (ja) 2−アルキル−4−クロロ−5−ヒドロキシメチルイミダゾール誘導体の製造法
HK1141785B (en) Process and intermediates for preparing integrase inhibitors
JPH1025293A (ja) 新規なイミダゾピロロキノリン化合物

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20170607

MKLA Lapsed

Effective date: 20220301

MKLA Lapsed

Effective date: 20200831